Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Oral Tranexamic Acid After Primary Total Knee Arthroplasty
NCT07494032Not yet recruiting
- Sponsor
- NYU Langone Health
- Start
- May 2026
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in knee arthropathy comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Knee Injury and Osteoarthritis Outcome Score for Joint Replacement at 12 months. Planned start May 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
knee arthropathy
Beyond the preview
Go deeper on NCT07494032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07494032.